Tell FDA: Please Prioritize COPD Cures and Treatments

The Food and Drug Administration (FDA) is launching the next round of its Patient-Focused Drug Development Initiative meetings and is asking patients and the American public about their priorities for treatments and cures for diseases.

More than 11 million Americans have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and as many as 13 million may have the disease and not know it. COPD—which includes emphysema and chronic bronchitis—is the 3rd leading cause of death in the U.S. but there is no cure for it.

The American Lung Association thinks COPD should be on FDA's list and we would like your help in asking FDA to prioritize and include COPD on its list. FDA needs to hear from you that cures and treatments for COPD must be a priority.

Thank you for all you do.



Paul Billings
Senior Vice President, Advocacy and Education
American Lung Association

** If you wish you may edit the below letter to share a personal experience of how you or a loved one has been impacted by COPD and why FDA must give priority to finding cures and better treatments for COPD. These personal stories are very powerful and important.

Recipients

  • Commissioner FDA Commissioner Margaret Hamburg

Contact

*Required fields
 

If you take action and have not already registered, you will receive periodic updates and communications from American Lung Association.

Message

Docket ID No. FDA-2012-N-0967

Dear Commissioner Hamburg,

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]